The resolution designates the first full week of May each year as Tardive Dyskinesia Awareness Week in New Jersey. Tardive Dyskinesia (TD) is a serious neurological condition characterized by uncontrollable movements, often resulting from the use of dopamine receptor blocking agents (DRBAs), such as antipsychotics prescribed for mental health conditions like schizophrenia and bipolar disorder. With approximately 1.1 million adults in New Jersey living with mental illness, many are at risk of developing TD due to their treatment. The resolution emphasizes the need for regular screenings and monitoring for TD, as early diagnosis and intervention can significantly improve outcomes.

The initiative aims to raise public awareness about TD, its symptoms, and the importance of early detection, as many individuals remain undiagnosed and unaware of their condition. The stigma associated with TD can lead to social and emotional challenges for those affected, further complicating their mental health. By establishing Tardive Dyskinesia Awareness Week, the resolution seeks to encourage New Jerseyans to recognize the signs of TD and seek appropriate medical care, ultimately fostering a more informed and supportive environment for individuals living with this disorder.